ライフサイエンスコーパス: Bifidobacterium

1 albeit with an especially high abundance of Bifidobacterium.

2 tobacillus + Lactococcus (6 x 10(10) CFU/g), Bifidobacterium (1 x 10(10)/g), Propionibacterium (3 x 1

3 a gene-diet interaction in the regulation of Bifidobacterium abundance.

4 ial markers: Bacteroidales HF183 (HF183) and Bifidobacterium adolescentis (BifAd); one viral marker:

5 e two most dominant Bifidobacterium species, Bifidobacterium adolescentis and Bifidobacterium pseudoc

6 ned with the GH5 enzyme stimulated growth of Bifidobacterium adolescentis but not of Lactobacillus br

7 an symbiont bacterial species, in particular Bifidobacterium adolescentis, that could, alone, induce

8 abundance of certain bacteria (for example, Bifidobacterium, Akkermansia and Faecalibacterium), high

9 Oral administration of Bifidobacterium alone improved tumor control to the same

10 ment of early microbiota and to increase the Bifidobacterium amounts as observed in human-milk-fed in

11 cteroides, Roseburia-Eubacterium rectale and Bifidobacterium and an increase of Enterobacteriaceae, D

12 Comparison to the Bifidobacterium and B. breve core genomes highlights a h

13 Evidence from measurements of Bifidobacterium and bacterial diversity analysis suggest

14 that the relative abundance of Allobaculum, Bifidobacterium and Coriobacteriaceae taxa associated wi

15 ignificant increases in species of the genus Bifidobacterium and decreases in Bacteroides vulgatus wi

16 These include absence of Bifidobacterium and differences in microbial composition

17 against select gut commensals (Bacteroides, Bifidobacterium and Lactobacillus species), and were non

18 support a relationship between abundances of Bifidobacterium and of putative pathogens or a significa

19 Bifidobacterium and Prevotella amounts were significantl

20 Chronic RW consumption increases Bifidobacterium and Prevotella amounts, which may have b

21 We replicate an association between Bifidobacterium and the lactase (LCT) gene locus and ide

22 ly isolated include Aerococcus, Gardnerella, Bifidobacterium, and Actinobaculum.

23 cycles of Lactobacillus acidophilus La-5 and Bifidobacterium animalis BB12.

24 d milk product containing dairy starters and Bifidobacterium animalis potentiates colonic short chain

25 Escherichia coli, Lactobacillus acidophilus, Bifidobacterium animalis subsp lactis, Faecalibacterium

26 The FMPP contained Bifidobacterium animalis subsp Lactis, Streptococcus the

27 and EP-HN019, 1 mL of suspensions containing Bifidobacterium animalis subsp. lactis (B. lactis) HN019

28 ei subsp. paracasei (L. casei 01); QB - with Bifidobacterium animalis subsp. lactis (BB 12); and QC,

29 We present the complete genomes of Bifidobacterium animalis subsp. lactis B420 and Bi-07.

30 comprising, Lactobacillus acidophilus LA-5, Bifidobacterium animalis subsp. lactis BB-12 and Propion

31 assette (ABC) transporter from the probiotic Bifidobacterium animalis subsp. lactis Bl-04 binds alpha

32 consumed a fermented milk product containing Bifidobacterium animalis subsp. lactis DN-173 010 strain

33 ct of 4-week use of yogurt supplemented with Bifidobacterium animalis subsp. lactis DN-173010 versus

34 robiotic fermented milks were produced using Bifidobacterium animalis subsp. lactis HN019 in co-cultu

35 of the study was to investigate the role of Bifidobacterium animalis subsp. lactis in preventing nos

36 Comparative genomic analysis of two Bifidobacterium animalis subsp. lactis strains revealed

37 ysiological responses of two fully sequenced Bifidobacterium animalis subsp. lactis strains, BL-04 an

38 sei IMVB-7280, Bifidobacterium animalis VKL, Bifidobacterium animalis VKB) at a dose of 50 mg/kg (5 x

39 trains (2:1:1 Lactobacillus casei IMVB-7280, Bifidobacterium animalis VKL, Bifidobacterium animalis V

40 bacillus reuteri, Lactobacillus casei GG, or Bifidobacterium animalis) in the gastrointestinal tracts

41 acillus reuteri, Lactobacillus casei GG, and Bifidobacterium animalis) to colonize, infect, stimulate

42 quencing of the 16S ribosomal RNA identified Bifidobacterium as associated with the antitumor effects

43 er of Enterococcus, Prevotella, Bacteroides, Bifidobacterium, Bacteroides uniformis, Eggerthella lent

44 cillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium bifidum and Streptococcus faecium) in ca

45 ether consuming Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and B. longum MM-2 compare

46 n conducted until now, inferred pathways for Bifidobacterium bifidum include perchlorate reduction vi

47 Whole-genome transcription profiling of Bifidobacterium bifidum PRL2010, a strain isolated from

48 f Bifidobacterium longum subsp. infantis and Bifidobacterium bifidum using individual HMO, and compar

49 tal of 10(7) colony-forming units (CFU)/g of Bifidobacterium bifidum, Bifidobacterium breve, Bifidoba

50 obacillus rhamnosum, Bifidobacterium longum, Bifidobacterium bifidum, Saccharomyces boulardi, Sacchar

51 rmentation of okara(ET) by a pure culture of Bifidobacterium bifidus was mainly represented by acetic

52 In comparison, Bifidobacterium breve ATCC 15700 showed significantly le

53 d to test the effectiveness of the probiotic Bifidobacterium breve BBG-001 to reduce necrotising ente

54 g fed with a diet containing scGOS/lcFOS and Bifidobacterium breve M-16V (GF/Bb) or a control diet.

55 ism by which scGOS/lcFOS in combination with Bifidobacterium breve M-16V protects against acute aller

56 supplementation for 8 wk with human-derived Bifidobacterium breve strains on fat distribution and co

57 Here we show that Bifidobacterium breve UCC2003 produces a cell surface-as

58 5 transposon mutant library of the commensal Bifidobacterium breve UCC2003 that was further character

59 ng units (CFU)/g of Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum, B. longum

60 otics had a significantly lower abundance of Bifidobacterium (by 55%; 95% CI, 43% to 87%; P = .006; a

61 nt, probiotic, Lactobacillus, Saccharomyces, Bifidobacterium, Candida, gastrointestinal- system, vagi

62 Veillonellaceae sp. HOT 155 (p < 0.01), and Bifidobacterium Cluster 1 (p = 0.11), and by qPCR, Strep

63 antitative perspective of the early-life gut Bifidobacterium colonization and shows how factors such

64 myces odontolyticus, Actinomyces meyeri, and Bifidobacterium dentium were all positive for so-called

65 Relative abundance of lactose-fermenting Bifidobacterium, Faecalibacterium, and Lactobacillus wer

66 Instead, Bifidobacterium, Gardnerella, Prevotella, Pseudomonas, o

67 association of a functional LCT SNP with the Bifidobacterium genus (P = 3.45 x 10(-8)) and provide ev

68 enetic variability of (pro)phages within the Bifidobacterium genus, a dominant bacterial group of the

69 It is noteworthy that the Bifidobacterium genus, which is commonly used in probiot

70 s, Enterobacteriaceae, Escherichia coli, and Bifidobacterium in apple cultured faeces tended to resem

71 re increased abundances of Lactobacillus and Bifidobacterium in resistant mice.

72 utes, increased Bacteroidetes, and decreased Bifidobacterium in the microbiome of AD participants.

73 Most of the members of the genus Bifidobacterium, including the related organism Alloscar

74 Newborn rat pups were given Bifidobacterium infantis (10(9) organisms per animal dai

75 ulating material for two probiotic bacteria: Bifidobacterium infantis and Lactobacillus plantarum by

76 e changes are prevented by administration of Bifidobacterium infantis, a probiotic known to decrease

77 ed the aggregation of a rod-shaped bacteria, Bifidobacterium infantis, during capillary electrophores

78 reported for a number of organisms including Bifidobacterium infantis.

79 linical significance of 15 A. omnicolens and Bifidobacterium isolates identified by 16S rRNA gene seq

80 movements/wk), and this was significant for Bifidobacterium lactis (WMD: 1.5 bowel movements/wk; 95%

81 x 10(7) colony-forming units (CFU)/g each of Bifidobacterium lactis and Streptococcus thermophilus, f

82 (Lactobacillus rhamnosus strain GG [LGG] and Bifidobacterium lactis Bb12 [Bb12]), mimicking gut comme

83 with Lactobacillus paracasei CNCM I-2116 or Bifidobacterium lactis CNCM I-3446 had a treatment effec

84 er all 28 days, the cheese supplemented with Bifidobacterium lactis in its isolated form showed the h

85 probiotics, Lactococcus lactis NCC 2287 and Bifidobacterium lactis NCC 2818, were tested in a murine

86 biota co-metabolism were further modified by Bifidobacterium lactis NCC2818 supplementation, although

87 nd that, when orally administered to humans, Bifidobacterium longum AH1206 stably persists in the gut

88 e we investigate how two commensal bacteria, Bifidobacterium longum and Bacteroides fragilis, represe

89 ning Bifidobacterium pseudocatenulatum G4 or Bifidobacterium longum BB536 on plasma lipids, lipid per

90 receive (1) Lactobacillus rhamnosus LPR and Bifidobacterium longum BL999 (LPR+BL999), (2) L paracase

91 eloped to quantify the consumption of FOS by Bifidobacterium longum bv. infantis using a calibration

92 te genome sequence of an intestinal isolate, Bifidobacterium longum DJO10A that was minimally culture

93 Viability of Bifidobacterium longum in soymilk added with polysacchar

94 actobacillus delbrueckii ssp. bulgaricus and Bifidobacterium longum in soymilk supplemented with tea

95 of AXOS in a complex fermentation medium by Bifidobacterium longum LMG 11047.

96 prospective study to evaluate the effects of Bifidobacterium longum NCC3001 (BL) on anxiety and depre

97 In this study, the mechanisms through which Bifidobacterium longum strain BB68 affects the longevity

98 l elucidation of the major polar lipids from Bifidobacterium longum subs. infantis.

99 Here we screened infant-gut isolates of Bifidobacterium longum subsp. infantis and Bifidobacteri

100 d the utility of a beta-1,3-galactosidase in Bifidobacterium longum subsp. infantis ATCC 15697 (B. in

101 Accordingly, the complete genome sequence of Bifidobacterium longum subsp. infantis ATCC15697 reflect

102 Bifidobacterium longum subsp. infantis efficiently consu

103 llel glycoprofiling documented that numerous Bifidobacterium longum subsp. infantis strains preferent

104 icular infant-associated commensals, such as Bifidobacterium longum subsp. infantis, consume neutral

105 In our hospital, we documented 2 cases of Bifidobacterium longum subspecies infantis bacteremia in

106 The counts of Bifidobacterium longum were higher in samples (n = 17) f

107 idobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum, B. longum subspecies infantis (i

108 illus acidophillus, Lactobacillus rhamnosum, Bifidobacterium longum, Bifidobacterium bifidum, Sacchar

109 sequence similarity to the O-glycosidase of Bifidobacterium longum.

110 al species, Bacteroides thetaiotaomicron and Bifidobacterium longum.

111 iota is often colonized by two subspecies of Bifidobacterium longum: subsp. infantis (B. infantis) an

112 t role in caries initiation and that a novel Bifidobacterium may be a major pathogen in deep caries.

113 Lactobacillus and bifidobacterium numbers were linked with low CAI.

114 istration of probiotic bacteria of the genus Bifidobacterium on experimental periodontitis (EP) in ra

115 igation was to develop baking products using Bifidobacterium pseudocatenulatum ATCC27919, a phytase p

116 he effect of a yoghurt supplement containing Bifidobacterium pseudocatenulatum G4 or Bifidobacterium

117 um species, Bifidobacterium adolescentis and Bifidobacterium pseudocatenulatum, and an increased abun

118 sing cell numbers, Actinomyces gerencseriae, Bifidobacterium, S. mutans, Veillonella, S. salivarius,

119 trials (RCTs) of probiotics (Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Enterococ

120 four species: A. omnicolens (five isolates), Bifidobacterium scardovii (four isolates), B. longum (tw

121 inal bacterial genera such as Lactobacillus, Bifidobacterium, Snodgrassella, and Gilliamella were det

122 as a Facklamia sp., Eubacterium tenue, and a Bifidobacterium sp.

123 ry, the quantity of Lactic Acid Bacteria and Bifidobacterium sp. increased concurrently during the co

124 acillus casei, L. reuteri, L. acidophilus, a Bifidobacterium sp., Lactococcus lactis, or a Bacillus s

125 arriage of eight signature infant-associated Bifidobacterium species (B. longum, B. breve, B. bifidum

126 in adequate relief of symptoms (P = .52) or Bifidobacterium species (P = .68).

127 s were adequate relief of symptoms and stool Bifidobacterium species abundance at 4 weeks.

128 mentation of GOS selectively increased fecal Bifidobacterium species abundance, but this did not prod

129 al sources associated with A. omnicolens and Bifidobacterium species and addresses identification pro

130 linical significance of A. omnicolens and of Bifidobacterium species are unclear.

131 but not placebo, increased the abundance of Bifidobacterium species in feces by 5-fold (P = .009; q

132 Breast milk enhances the predominance of Bifidobacterium species in the infant gut, probably due

133 his, we have determined the ability of three Bifidobacterium species isolated from the faeces of newb

134 omparative genome sequence analysis of three Bifidobacterium species provided a core genome set of 1,

135 udy highlights two major strategies found in Bifidobacterium species to process HMO, and presents det

136 placebo (192 +/- 93) (P = .721) Abundance of Bifidobacterium species was lower in fecal samples from

137 addition, a dearth of the two most dominant Bifidobacterium species, Bifidobacterium adolescentis an

138 e multistrain probiotic increased numbers of Bifidobacterium species, compared with placebo, and migh

139 es involved in immunity development, such as Bifidobacterium species, Sutturella wadsworthia, and Clo

140 ides-Porphyromonas-Prevotella group (BPP) to Bifidobacterium species.

141 predominance of beneficial Lactobacillus and Bifidobacterium species.

142 lyticum, Mycoplasma hominis, and Gardnerella/Bifidobacterium species.

143 rectale (cluster XIVab), Bacteroidetes, and Bifidobacterium spp, but decreased segmented filamentous

144 s a significant time-by-group interaction on Bifidobacterium spp. (P = 0.008) and Lactobacillus/Pedio

145 h Sulfatrim restored the level of intestinal Bifidobacterium spp. and Clostridium spp.

146 in a transient increase in the abundance of Bifidobacterium spp. and Clostridium spp. in fecal sampl

147 ere was a nonsignificant trend toward higher Bifidobacterium spp. in the Fe+GOS group (P = 0.099).

148 in reaction showed a significant increase in Bifidobacterium spp. in the OI group compared with contr

149 olysates did not generally support growth of Bifidobacterium spp. in vitro.

150 ase (p < 0.01) in the Lactobacillus spp. and Bifidobacterium spp. populations was observed during the

151 The ratio of BPP to Bifidobacterium spp. rRNA in infants randomly assigned t

152 sal bacterial communities (Bacteroides spp., Bifidobacterium spp., Clostridium leptum group, Enteroba

153 omoted growth of beneficial bacteria such as Bifidobacterium spp., Lactobacillus spp., Bacteroides ac

154 This Bifidobacterium strain contributed to myo-inositol hexak

155 he-shelf probiotic preparations that include Bifidobacterium strains also drove intestinal Th17 cell

156 obacillus and mutans streptococci (MS), most Bifidobacterium strains and non-mutans streptococci (non

157 erm colonization (24 mo) of the supplemented Bifidobacterium strains was not detected.

158 c properties in vitro with Lactobacillus and Bifidobacterium strains.

159 Here, genome analyses of 47 representative Bifidobacterium (sub)species revealed the genes predicte